Published in J Neurosci on March 15, 2000
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Putting brain training to the test. Nature (2010) 3.88
Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull (2011) 3.14
Parietal cortex and representation of the mental Self. Proc Natl Acad Sci U S A (2004) 2.73
Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry (2010) 2.00
Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct (2005) 1.87
Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry (2011) 1.78
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann N Y Acad Sci (2008) 1.58
Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci (2011) 1.55
Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One (2008) 1.54
Executive cognitive functions and impulsivity as correlates of risk taking and problem behavior in preadolescents. Neuropsychologia (2009) 1.43
Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. Am J Psychiatry (2008) 1.42
Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav (2011) 1.37
Cognitive enhancement by drugs in health and disease. Trends Cogn Sci (2010) 1.35
Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology (2009) 1.25
Methylphenidate disrupts social play behavior in adolescent rats. Neuropsychopharmacology (2008) 1.25
Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci U S A (2010) 1.25
Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping". Subst Abuse Treat Prev Policy (2013) 1.20
Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) (2007) 1.18
Variations in catechol-O-methyltransferase gene interact with parenting to influence attention in early development. Neuroscience (2009) 1.16
Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry (2008) 1.15
Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence. Cereb Cortex (2006) 1.15
Modeling students' instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theory. Biopsychosoc Med (2014) 1.14
Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Med Ethics (2009) 1.13
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A (2001) 1.12
The effects of background white noise on memory performance in inattentive school children. Behav Brain Funct (2010) 1.11
Does adolescent risk taking imply weak executive function? A prospective study of relations between working memory performance, impulsivity, and risk taking in early adolescence. Dev Sci (2011) 1.11
Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology (2011) 1.10
Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biol Psychiatry (2010) 1.10
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol (2007) 1.08
Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry (2013) 1.08
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci (2006) 1.07
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. Psychopharmacology (Berl) (2010) 1.07
How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology (2010) 1.06
Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav (2012) 1.06
C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology (Berl) (2006) 1.06
Neuropsychological profile of executive function in girls with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol (2010) 1.05
Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage (2009) 1.04
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology (2012) 1.04
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2004) 1.02
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse (2009) 1.02
Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Front Syst Neurosci (2014) 1.00
The likelihood of cognitive enhancement. Pharmacol Biochem Behav (2011) 1.00
Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate. Curr Neuropharmacol (2008) 0.98
Inhibitory control of eye movements during oculomotor countermanding in adults with attention-deficit hyperactivity disorder. Exp Brain Res (2003) 0.97
The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biol Psychiatry (2014) 0.97
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage (2012) 0.96
The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex. J Pediatr (2009) 0.96
Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction. Cereb Cortex (2012) 0.95
Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology (Berl) (2010) 0.93
Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) (2006) 0.93
When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. Psychopharmacology (Berl) (2008) 0.92
Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology (2010) 0.92
Atomoxetine facilitates attentional set shifting in adolescent rats. Dev Cogn Neurosci (2011) 0.91
Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes. Psychopharmacology (Berl) (2005) 0.91
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother (2010) 0.91
Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct (2006) 0.91
Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl) (2010) 0.90
Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers. Psychopharmacology (Berl) (2011) 0.89
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain (2013) 0.89
The role of prefrontal catecholamines in attention and working memory. Front Neural Circuits (2014) 0.89
Working memory capacity predicts effects of methylphenidate on reversal learning. Neuropsychopharmacology (2013) 0.89
Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder. Behav Brain Funct (2012) 0.87
Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics. Cereb Cortex (2003) 0.87
Modulation of social influence by methylphenidate. Neuropsychopharmacology (2012) 0.87
Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Eur J Neurosci (2010) 0.86
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate. Curr Neuropharmacol (2016) 0.86
Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy. Psychopharmacology (Berl) (2011) 0.85
Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology (Berl) (2004) 0.85
The ethics of elective psychopharmacology. Int J Neuropsychopharmacol (2011) 0.85
1H MRSI of middle frontal gyrus in pediatric ADHD. J Psychiatr Res (2012) 0.84
Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report. J Atten Disord (2010) 0.84
Attentional blink in adults with attention-deficit hyperactivity disorder. Influence of eye movements. Exp Brain Res (2003) 0.84
Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex. Neurobiol Learn Mem (2013) 0.83
Augmentation-related brain plasticity. Front Syst Neurosci (2014) 0.83
Oral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive task. Neuropsychopharmacology (2011) 0.83
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study. Psychopharmacology (Berl) (2011) 0.83
Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm (Vienna) (2005) 0.83
Sleep Deprivation Impairs and Caffeine Enhances My Performance, but Not Always Our Performance. Pers Soc Psychol Rev (2016) 0.82
Dopaminergic influences on emotional decision making in euthymic bipolar patients. Neuropsychopharmacology (2013) 0.82
Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals. Front Syst Neurosci (2014) 0.82
Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts. BMC Med Ethics (2016) 0.82
Waiting Impulsivity: The Influence of Acute Methylphenidate and Feedback. Int J Neuropsychopharmacol (2015) 0.80
Towards medication-enhancement of cognitive interventions in schizophrenia. Handb Exp Pharmacol (2012) 0.80
Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacology (Berl) (2006) 0.80
Use of magnetic resonance imaging in pharmacogenomics. Br J Clin Pharmacol (2014) 0.80
Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats. Neuropharmacology (2009) 0.80
An investigation into aripiprazole's partial D2 agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers. Psychopharmacology (Berl) (2016) 0.80
Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Psychopharmacology (Berl) (2010) 0.79
Early markers of cognitive enhancement: developing an implicit measure of cognitive performance. Psychopharmacology (Berl) (2013) 0.79
Effects of dietary tryptophan and phenylalanine-tyrosine depletion on phasic alertness in healthy adults - A pilot study. Food Nutr Res (2015) 0.79
Methylphenidate improves performance on the radial arm maze in periadolescent rats. Neurotoxicol Teratol (2008) 0.79
The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats. Neuropharmacology (2014) 0.79
The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol Imaging (2003) 0.79
Chronic Ritalin administration during adulthood increases serotonin pool in rat medial frontal cortex. Iran Biomed J (2013) 0.78
Preliminary investigation of the influence of dopamine regulating genes on social working memory. Soc Neurosci (2014) 0.78
Instrumental learning in ADHD in a context of reward: intact learning curves and performance improvement with methylphenidate. J Abnorm Child Psychol (2015) 0.78
Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci (2000) 8.71
Dissociation in prefrontal cortex of affective and attentional shifts. Nature (1996) 5.30
Safe removal of retained ventricular catheters using intraluminal choroid plexus coagulation. Technical note. J Neurosurg (1995) 5.20
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science (2001) 4.25
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Central cholinergic systems and cognition. Annu Rev Psychol (1997) 3.80
Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia (1990) 3.79
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex (2001) 3.67
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain (2007) 3.62
Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology (1999) 3.60
Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia (1994) 3.46
Cognitive inflexibility after prefrontal serotonin depletion. Science (2004) 3.44
The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev (2001) 3.33
Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med (1992) 3.00
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry (2007) 2.94
Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci (1999) 2.92
Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci (1999) 2.86
Emotional bias and inhibitory control processes in mania and depression. Psychol Med (1999) 2.85
Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain (2008) 2.82
Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci (1999) 2.81
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain (2007) 2.77
Does prediction of outcome alter patient management? Lancet (1993) 2.75
Tacrine in Alzheimer's disease. Lancet (1991) 2.67
Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature (1997) 2.66
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia (1991) 2.56
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry (2005) 2.54
Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res (2003) 2.50
Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing. J Neurosci (1997) 2.41
Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol (2006) 2.36
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol (2001) 2.27
Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci (1996) 2.27
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia (2000) 2.26
Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci (2005) 2.24
Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery (1997) 2.23
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn (2004) 2.19
The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev (2005) 2.19
Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci (2000) 2.19
Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience (1989) 2.19
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci (2000) 2.18
The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology (Berl) (2000) 2.16
Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry (2004) 2.16
A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc (1998) 2.13
Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res (1983) 2.11
Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) (1997) 2.08
Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain (1993) 2.07
Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav Brain Res (2002) 2.06
Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia (1997) 1.99
Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology (Berl) (1993) 1.99
Evidence for executive dysfunction in autism. Neuropsychologia (1994) 1.98
Drug addiction: bad habits add up. Nature (1999) 1.97
Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain (1999) 1.95
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci (2000) 1.94
The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience (1991) 1.90
Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience (1991) 1.90
Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl) (1984) 1.89
Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex (2006) 1.89
Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry (2007) 1.89
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87
Monitoring of cerebral autoregulation in head-injured patients. Stroke (1996) 1.87
The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex (1996) 1.85
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain (1998) 1.84
Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med (1996) 1.84
Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex (2001) 1.83
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) (1997) 1.83
Cerebral autoregulation following head injury. J Neurosurg (2001) 1.82
Dissociable roles of the central and basolateral amygdala in appetitive emotional learning. Eur J Neurosci (2000) 1.81
Cerebrovascular reactivity during hypothermia and rewarming. Br J Anaesth (2007) 1.80
Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav Neurosci (1997) 1.78
Disconnection of the anterior cingulate cortex and nucleus accumbens core impairs Pavlovian approach behavior: further evidence for limbic cortical-ventral striatopallidal systems. Behav Neurosci (2000) 1.78
Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci (2002) 1.78
Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl) (1996) 1.77
Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology (Berl) (2000) 1.77
Reproducibility of quantitative CT perfusion imaging. Br J Radiol (2001) 1.76
Decision-making cognition in mania and depression. Psychol Med (2001) 1.75
Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res (1999) 1.72